All News

Investigators found that longer durations of GLP-1 use were associated with increased risk of nAMD.

Pharmacy team members can help patients prepare for upcoming travels, ensuring they are up to date with the recommended vaccines for their locations.

Lauren Angelo, PharmD, MBA, associate dean of academic affairs at Rosalind Franklin University of Medicine and Science, highlights significant concerns about the evolving landscape of COVID-19 vaccine policy.

In this episode of the podcast, Shawn and Jesse discuss the benefits of being easy to do business with.

Investigators found that simvastatin added to escitalopram for patients with obesity and major depressive disorder did not have increased antidepressive effects.

Postmenopausal women who ate mango daily for 2 weeks had lower blood pressure measures and lower total cholesterol.

Lauren Angelo, PharmD, MBA, associate dean of academic affairs at Rosalind Franklin University of Medicine and Science, discusses the changing recommendations for COVID-19 vaccination.

A significant number of patients remain unaware of their diabetes, signaling a need for better diagnostic efforts.

ASC40 blocks facial sebum production by inhibiting de novo lipogenesis in sebocytes and inflammation by decreasing cytokine secretion and Th17 differentiation.

The primary challenges include disruption in medication supply and increased demand for essential medications due to heightened health concerns.

A conversation with Erin Albert, MBA, PharmD, JD, DASPL, chief of pharmacy relations, network and privacy, at Cost Plus Drugs.

Social determinants of health have significant impacts on health and quality of life, but little is known about the impact during menopause.

Esaxerenone is a nonsteroidal mineralocorticoid receptor blocker that is being studied for its effectiveness for diabetes-associated mineralocorticoid receptor-related hypertension.

In the aftermath of natural disasters, pharmacists play an essential role in the disaster relief team.

The most common barriers to vaccination included finances, logistics, availability of information, and hesitancy or refusal.

Invasive pneumococcal disease is a cause of morbidity and mortality in the US, despite the availability of vaccination against the disease.

Results from a phase 2 trial showed that semaglutide combined with trevogrumab, with or without garetosmab, helped patients preserve lean mass and achieve greater fat loss.

Pharmacists are indispensable members of the disaster relief team, playing a crucial role in ensuring the continuity of care during and after a natural disaster.

The new approval is in line with recommendations that suggest booster vaccination for older adults and patients aged 12 to 64 with at least 1 or more underlying risk factors.

The event will focus on revenue stream diversification, providing independent pharmacies with seeds of innovation and practical tools to cultivate new avenues for growth in pharmacy.

Joey Mattingly, PharmD, MBA, PhD, and Marta Wosinska, PhD, discussed what pharmacy businesses can do to prepare for the potential implementation of tariffs on pharmaceutical products.

Although there is no cure for MS, treatment focuses on recovery from attacks, reducing relapse, slowing disease progression, and managing multiple sclerosis symptoms.

In a session at PQA 2025, presenters discussed the impact of SDoH on health outcomes and how pharmacy teams can identify and address barriers.

Drug Topics was joined by Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, to discuss the potential impact tariffs may have if they are widely implemented within the pharmaceutical industry.

In the suit, the companies claim the law puts an unconstitutional restriction on interstate commerce.

The results place emphasis on female parents with low socioeconomic status for both declines in mental and physical health.

Health care economist Marta Wosinska, PhD, senior fellow with The Brookings Institution, discussed the potential impact pharmaceutical tariffs may have on access to generic and brand-name drugs.

The results show promise, as vision typically improves the most during the first 4 weeks, but with lamivudine, vision continued to improve in the following 4 weeks.